A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design

Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activity

(2011) Małgorzata Siger et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Fingolimod for the treatment of relapsing multiple sclerosis

(2010) Douglas R Jeffery et al.   Expert Review of Neurotherapeutics

Assessing changes in relapse rates in multiple sclerosis

(2010) Seidu Inusah et al.   Multiple Sclerosis Journal

Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis

(2010) Sebastian Doerck et al.   PLoS One

New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS

(2010) Marco Prinz et al.   TRENDS IN MOLECULAR MEDICINE

Chemotherapeutics in the treatment of multiple sclerosis

(2010) Bernd C. Kieseier et al.   Therapeutic Advances in Neurological Disorders

Autologous T-Cell Vaccination for Multiple Sclerosis

(2009) Arthur A Vandenbark et al.   BIODRUGS

Autologous attenuated T-cell vaccine (Tovaxin®) dose escalation in multiple sclerosis relapsing–remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies

(2009) B. Loftus et al.   CLINICAL IMMUNOLOGY

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate

(2009) Ruth Arnon et al.   JOURNAL OF NEURAL TRANSMISSION

Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis

(2009) Juergen Haas et al.   JOURNAL OF NEUROIMMUNOLOGY

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role

(2009) Roland Liblau   JOURNAL OF THE NEUROLOGICAL SCIENCES

The mechanism of action of glatiramer acetate treatment in multiple sclerosis

(2009) M. K. Racke et al.   NEUROLOGY

Interferon-β treatment for relapsing multiple sclerosis

(2008) Bianca Weinstock-Guttman et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

(2008) O. Stuve et al.   NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE